Volume 39, Issue 2 pp. 89-92
Full Access

Frequency of the phenylalanine deletion (ΔF508) in the CF gene of Belgian cystic fibrosis patients

Jan G. Wauters

Jan G. Wauters

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
Jan Hendrickx

Jan Hendrickx

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
Paul Coucke

Paul Coucke

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
Lieve Vits

Lieve Vits

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
Karel Stuer

Karel Stuer

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
Lutgard van Schil

Lutgard van Schil

St-Vincentius Hospital, Antwerp, Belgium

Search for more papers by this author
Bart J. van der Auwera

Bart J. van der Auwera

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
August Van Elsen

August Van Elsen

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
Jan Dumon

Jan Dumon

Department of Medical Genetics, University of Antwerp-U.I.A.

Search for more papers by this author
Patrick J. Willems

Corresponding Author

Patrick J. Willems

Department of Medical Genetics, University of Antwerp-U.I.A.

Universitaire Instelling Antwerpen Universiteitsplein 1 2610 Wilrijk BelgiumSearch for more papers by this author
First published: February 1991
Citations: 1

Abstract

Cloning and sequencing of the CF gene has identified a three-base-pair deletion (ΔF508) responsible for CF in the majority of CF patients (Kerem et al. 1989). We have used the polymerase chain reaction with oligonucleotide primers bridging the ΔF308 deletion to analyze the presence or absence of this mutation in the Belgian CF population. The ΔF306 mutation was present in 80% (57 on 71) of CF chromosomes from 36 unrelated Belgian CF families from the region of Antwerp. This mutation was associated with haplotype B for the KM.19–XV-2c RFLPs as 93% (53 on 57) of the CF chromosomes with the Δ306 mutation carried haplotype B.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.